Page last updated: 2024-11-03

primaquine and Travel Sickness

primaquine has been researched along with Travel Sickness in 2 studies

Primaquine: An aminoquinoline that is given by mouth to produce a radical cure and prevent relapse of vivax and ovale malarias following treatment with a blood schizontocide. It has also been used to prevent transmission of falciparum malaria by those returning to areas where there is a potential for re-introduction of malaria. Adverse effects include anemias and GI disturbances. (From Martindale, The Extra Pharmacopeia, 30th ed, p404)
primaquine : An N-substituted diamine that is pentane-1,4-diamine substituted by a 6-methoxyquinolin-8-yl group at the N(4) position. It is a drug used in the treatment of malaria and Pneumocystis pneumonia.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tickell-Painter, M1
Maayan, N1
Saunders, R1
Pace, C1
Sinclair, D1
Reuken, PA1
Baier, M1
Hagel, S1
Eisermann, P1
Stallmach, A1
Rödel, J1

Reviews

1 review available for primaquine and Travel Sickness

ArticleYear
Mefloquine for preventing malaria during travel to endemic areas.
    The Cochrane database of systematic reviews, 2017, 10-30, Volume: 10

    Topics: Adult; Antimalarials; Atovaquone; Child; Chloroquine; Doxycycline; Drug Combinations; Drug Resistanc

2017

Other Studies

1 other study available for primaquine and Travel Sickness

ArticleYear
Diagnosis of malaria in a traveler 9 months after returning from West Africa by
    Acta microbiologica et immunologica Hungarica, 2019, Sep-01, Volume: 66, Issue:3

    Topics: Africa, Western; Antimalarials; Atovaquone; Drug Combinations; Germany; Humans; Malaria; Male; Middl

2019